跳至主要内容
临床试验/NCT07205874
NCT07205874招募中不适用

Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)

Hospital Universitario La Paz1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年9月15日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
80
试验地点
1
主要终点
Scheuer's criteria

研究概览

简要总结

The goal of this observational study is to achieve early diagnosis of Primary Biliary Cholangitis (PBC) in patients with positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP) in adults aged 18-80 years with positive AMA and normal ALP. The main question it aims to answer is:

• Are there any predictive factors for histological PBC in patients with positive AMA and normal ALP? Participants will undergo a liver biopsy and specific blood tests if eligible based on inclusion and exclusion criteria.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Positive AMA (≥1:40 titer)
  • Persistently normal ALP

排除标准

  • Previously diagnosed with PBC, autoimmune hepatitis, or primary sclerosing cholangitis
  • Under treatment with ursodeoxycholic acid, fibrates, biologics or immunosuppressants including oral steroids
  • Contraindications for liver biopsy
  • Concomitant debilitating disease or poor prognosis
  • Pregnancy

结局指标

主要结局

Scheuer's criteria

时间窗: Just once, at enrollment

Liver biopsy samples

次要结局

  • Enhanced Liver Fibrosis (ELF) Score(Just once, at enrollment)
  • Tumor Necrosis Factor-alpha (TNF-α)(Just once, at enrollment)
  • Fibroblast Growth Factor 19 (FGF-19)(Just once, at enrollment)
  • Cytokine Profiling (Interleukin-6, -12, -23)(Just once, at enrollment)
  • Transforming Growth Factor-beta (TGF-β)(Just once, at enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

María Dolores Martín Arranz, PhD

Head of department

Hospital Universitario La Paz

研究点 (1)

Loading locations...

相似试验